Health
Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease – News-Medical.net
A recent study sed PBPK modeling to demonstrate the use of DEX PKs for the treatment of COVID-19 in patients with liver impairment….
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in December 2019. Studies have shown that between 3% to 8% of coronavirus disease 2019 (COVID-19) patients have pre-existing chronic liver disease (LD)….
Continue Reading
-
General8 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General11 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
General19 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’
-
General15 hours agoRenters surprise winners from cheaper mortgage deposits